X
  • What are the Novel Growth Opportunities for Gut Microbiome?
    Targeted gut microbiome technologies to drive transformational growth across the global healthcare landscape

    Click image to view it in full size

    This analysis identifies research initiatives focused on the development of gut microbiome therapeutics. Disruption of the gut microbiome causes a range of health issues, including gastrointestinal diseases, immuno-oncological diseases, and metabolic diseases.

    • Over the last decade, gut microbiome therapeutics have largely relied on untargeted approaches, such as fecal microbiome therapy (FMT), probiotics, prebiotics, and synbiotics.

    • However, technological advancements have resulted in the development of and demand for targeted interventions for microbiome therapeutics.

    • Emerging technologies in this space include targeted drugs, cultured commensals, bio-engineered commensals, and bacteriophage therapies.

  • Sign up for a complimentary Growth Pipeline Dialog™

    A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled industry intelligence, technology advancements, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.

    SCHEDULE YOUR DIALOG »

    HAVE A SUBSCRIPTION?
    Access Analysis Via